---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-003129"
form_type: "8-K"
ticker: "ZOMDF"
cik: "0001684144"
company_name: "Zomedica Corp."
filed_at: "2023-03-17T23:59:59+00:00"
generated_at: "2026-06-17T23:36:55.221201+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Zomedica appoints Peter Donato as CFO effective March 16, 2023; Ann Marie Cotter resigns

## Summary
- Ann Marie Cotter resigned as CFO effective March 16, will remain through April 15 for transition.
- Cotter receives 12 months base salary, prorated bonus, and stock option acceleration under separation agreement.
- New CFO Peter Donato has 30+ years experience; previously CFO at Standard Bariatrics acquired by Teleflex.
- Donato's compensation: $325k base salary, up to 40% annual bonus, $35k relocation bonus, and options for 5M shares.
- Options vest over four years; change-of-control severance includes one year salary and COBRA.

## SEC filing metadata
- accession: 0001654954-23-003129
- form_type: 8-K
- ticker: ZOMDF
- cik: 0001684144
- company_name: Zomedica Corp.
- filed_at: 2023-03-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1684144/000165495423003129/0001654954-23-003129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1684144/000165495423003129/zom_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-003129
- JSON: https://secwatch.observer/filing/0001654954-23-003129.json
- Plain text: https://secwatch.observer/filing/0001654954-23-003129.txt

## Key facts
- Executive change
  Ann Marie Cotter resigned as Chief Financial Officer at Zomedica Corp..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On March 16, 2023, Ann Marie Cotter resigned from employment as Chief Financial Officer of Zomedica Corp.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1684144/000165495423003129/0001654954-23-003129-index.htm
- Executive change
  Peter Donato was appointed as Chief Financial Officer at Zomedica Corp..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Also on March 16, 2023, Peter Donato was appointed as the Company’s Chief Financial Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1684144/000165495423003129/0001654954-23-003129-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.